Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 14:14:19.
doi: 10.1186/1471-2407-14-19.

High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagus

Zhimin Zhang, Hualiang Xiao, Fei Xie, Hui Zhang, Chuan Chen, He Xiao, Zhenzhou Yang, Dong Wang, Zengpeng Li, Ge Wang  1
Affiliations

High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagus

Zhimin Zhang et al. BMC Cancer. .

Abstract

Background: Primary small cell carcinoma of the esophagus (PSCCE) is a rare and aggressive tumor with poor prognosis. The aim of this study was to investigate the existence of EGFR, KRAS, PIK3CA and PTEN mutations in PSCCE.

Methods: Clinical-pathological data and paraffin-embedded specimens were collected from 38 patients. Exons 18 to 21 of EGFR, KRAS and PIK3CA status were analyzed by real-time PCR based on ARMS and Scorpion technology in all patients, and the PTEN gene was also screened using real-time PCR and high-resolution melting curve analysis (HRMA).

Results: Only 1 (2.63%) out of 38 patients had EGFR mutations in L858R missense, and KRAS and PIK3CA were not found in the mutational spot in all patients. However, PTEN mutations presented in 14 (36.84%) out of 38 patients, including exon 5 coding for PTEN missense mutation (n =4, 10.53%), exon 6 (n =7, 18.42%), concurrent exon 5 and exon 6 (n =2, 5.26%), and exon 8 (n =1, 2.63%). Concurrent mutations of these genes were not detected in all samples. No statistically significant associations were found between the clinicopathological features and the mutation status of PTEN.

Conclusions: The incidence of PTEN mutations in Chinese patients with PSCCE was higher than that of previous reports in other histological subtypes of esophageal cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A representative case of primary small cell carcinoma of the esophagus. Biopsy materials were shown in the histopathologic examination, and tumoral cells in the sample indicated CK, CgA, CD56, Syn, TTF-1 and Ki-67 with a positive immunoreactivity by immunohistochemical examination. (Magnification, ×200).
Figure 2
Figure 2
Amplification plots for PTEN mutations in exon 5,6,8 using High-resolution melting analysis. (A,B,C). Amplification plots for a sample containing no mutated in PTEN gene. A, exon 5; B, exon 6; C, exon 8. (D,E,F). Amplification plots for a sample containing mutated exon 5 and exon 6 in PTEN gene. D, exon 5; E, exon 6; F, exon 8. (G,H,I). Amplification plots for a sample containing a mutated exon 8 in PTEN gene. G, exon 5; H, exon 6; I, exon 8. The Y-axis shows the relative fluorescence for a measurement of the change in fluorescent signal versus a passive reference signal, X-axis shows the temperature (°C). Each sample was analyzed in triplicate or duplicate.
See this image and copyright information in PMC

References

    1. Pantvaidya GH, Pramesh CS, Deshpande MS, Jambhekar NA, Sharma S, Deshpande RK. Small cell carcinoma of the esophagus: the Tata Memorial Hospital experience. Ann Thorac Surg. 2002;74(6):1924–1927. doi: 10.1016/S0003-4975(02)04061-4. - DOI - PubMed
    1. Yekeler E, Koca T, Vural S. A rare cause of the cough: primary small cell carcinoma of esophagus-case report. Case Rep Med. 2012;2012:870783. - PMC - PubMed
    1. Sun KL, He J, Cheng GY, Chai LX. Management of primary small cell carcinoma of the esophagus. Chin Med J (Engl) 2007;120(5):355–358. - PubMed
    1. Kwak EL, Jankowski J, Thayer SP, Lauwers GY, Brannigan BW, Harris PL, Okimoto RA, Haserlat SM, Driscoll DR, Ferry D, Muir B, Settleman J, Fuchs CS, Kulke MH, Ryan DP, Clark JW, Sgroi DC, Haber DA, Bell DW. Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas. Clin Cancer Res. 2006;12(14 Pt1):4283–4287. - PMC - PubMed
    1. Sudo T, Mimori K, Nagahara H, Utsunomiya T, Fujita H, Tanaka Y, Shirouzu K, Inoue H, Mori M. Identification of EGFR mutations in esophageal cancer. Eur J Surg Oncol. 2007;33(1):44–48. doi: 10.1016/j.ejso.2006.10.034. - DOI - PubMed

Publication types